TASS

Supports comprehensive screening for infectious gastroenteritis with the BD MAX System

SPARKS, Maryland, May 12, 2014 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD ...
Seeking Alpha

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and ...
Business Insider

BD Launches Molecular Test For Detecting Tuberculosis And Multi-Drug Resistant TB

FRANKLIN LAKES, N.J., Oct. 16, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX™ MDR-TB ...
Seeking Alpha

BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec

FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced the expansion of its respiratory and sexually ...
News Medical

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening ...